Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Breakfast News - Tyman, Immedia & Aeoroma Comms.

Breakfast News - Tyman, Immedia & Aeoroma Comms.

Set menu


AIM:

 

Total number of AIM Companies (Incl Susp):

 

923*

 

Total number of AIM Companies trading:

 

856*

 

*as at close of business  30 October 2018

 

Standard List**  of Main Market:

 

Total number of Standard List Companies

 

(Incl Susp):

 

138*

 

Total number of Standard List Companies trading:

 

120*

 

*as at close of business 30 October 2018

 

NEX Growth Market:

 

Total number of NEX Growth Market Companies (Incl Susp):

 

88*

 

Total number of NEX Growth Market Companies trading:

 

86*               

 

*as at close of business 30 October 2018

 

*A corporate client of Hybridan LLP

 

**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity

 
Dish of the day

 

No Joiners Today

 

Off the menu      

 

Sky has left the London Stock Exchange (Main Premium) following the takeover by Comcast

          

Banquet Buffet

 

ECO Animal Health  (LON:EAH) 376.5p £246.3m

 

“ECO Animal Health, a wholly owned subsidiary of ECO Animal Health Group plc, and Pharmgate LLC of Wilmington, North Carolina, USA announced that the scope of their new joint venture established in April 2018, ECO-Pharm Limited, based in the Republic of Ireland has now been extended.

 

ECO-Pharm Limited will now be responsible for the registration, marketing, sale and distribution of a number of Pharmgate LLC swine vaccine products in the United Kingdom, the European Union and the Commonwealth of Independent States, Japan and Brazil. It is expected that further vaccine products will flow from our biologicals research and development pipeline.”

 

“This is an important milestone in the development of ECO-Pharm Limited. Swine vaccines account for half the animal health market for this species in Japan and almost a quarter of this market in Brazil.”

 

FY 2019E revs of £75.9m and EBITDA of £21.1m

 

 88 Energy (ASX:88E) 1.25p £63.54m

 

Update related to ongoing work on its conventional prospect portfolio at Project Icewine, located on the Central North Slope, Alaska.

 

Yukon Leases Maiden Resource: Net Mean Prospective Oil Resource - 90 MMBO

 

Cascade lead upgraded to prospect - Brookian Turbidite Fan Play

 

Additional prospectivity mapped within Staines Tongue Topset Play

 

Project Icewine Net Mean Prospective Oil Resource - 2,211 MMBO

 

Farm-out process continues as planned, with deal targeted prior to year-end 2018

 

Western Blocks Net Mean Prospective Oil Resource - 144 MMBO

 

Stacked Brookian objectives including Nanushuk Topset Play

 

The Winx-1 well is on schedule to commence drilling in February 2019

 

88 Energy Total Conventional Net Mean Prospective Oil Resource - 2,445 MMBO

 

Botswana Diamonds (LON:BOD) 0.9p £4.33m

 

Update on the Company's development plan for the Thorny River project in South Africa.

 

A mining contract has been concluded with Palaeo Minerals Pty Limited covering both bulk sampling activities and future full-scale mining.

 

The Contract will enable the Company to self-fund the Thorny River project from bulk sampling through to mine development, assuming positive results.

 

Indicated net royalties could be between US$2 to $7m annually based on current estimates.

 

The necessary regulatory approvals have been applied for.

 

Drill programme planned in 2019.

 

Sportech (LON:SPO) 44.6p £100.85m

 

FYDec18 update from international betting technology business.

 

“Following the reduction in Group size as a result of the sale of assets and subsequent shareholder distributions in 2017, key sales contracts now have a more significant impact on Group performance indicators. The Group now anticipates that certain expected sales contracts are unlikely to be secured in 2018 and therefore forecast Adjusted EBITDA, excluding Sports Betting investments, for 2018 will likely be 5% to 10% lower than the current market expectation of £8.5m. The latest forecast, however, would represent year on year Adjusted EBITDA growth of between 14% to 20%.”

 

The Group continues to work proactively with existing B2B clients across the US and with the state of Connecticut to extend the Group's existing pari-mutuel licence to conduct sports betting as a licensed "direct to consumer" operator.  The decision by the State is anticipated to be in 2019, when the legislative session resumes.

 

Benchmark Holdings (LON:BMK) 62.8p £337.2m

 

The aquaculture health, genetics and specialist nutrition business, is pleased to provide the following trading update for the year ended 30 Sept 2018.

 

Significant growth in revenues and underlying profit ahead of market expectations:

 

Revenues above £150m (unaudited) (2017: £140.2m), a growth of c.7%

 

Adjusted EBITDA above £16.5m (2017: £10.0m), a growth of 65%

 

Company compiled consensus of revenues of £156m and EBITDA of £15.8m

 

“Market conditions in our core salmon and shrimp markets remain favourable and the outlook is positive, with strong demographic and sustainability drivers, and an increasing trend towards professionalisation and consolidation amongst customers. This, combined with an increasing recognition of the role that our innovative products can play in boosting yield, quality and sustainability, provides us with confidence in the future outlook.”

 

FY2018E revs of £155m and EBITDA of £15.5m

 

Best of The Best (LON:BOTB) 236p £22.4m

 

“The online organiser of weekly competitions to win cars and other lifestyle prizes, announced that trading for the six months ended 31 Oct 2018 has been encouraging, with revenues and profits before tax generated tracking ahead of market expectations for the current financial year. Revenues are now almost entirely attributable to online sales, with only one physical site remaining at Birmingham Airport.

 

The Company is pleased to have been able to deliver a solid performance in the first half of the financial year, despite absorbing the burden of increased taxes as a result of the requirement to move from VAT to paying Remote Gaming Duty (RGD) in 2017. The Board notes, however, that as announced in the recent Budget, RGD is due to increase to from 15 to 21% from 1 Oct 2019. The Board will be taking steps to minimise the impact of this tax increase and will aim to maintain margins and profit growth over subsequent reporting periods.”

 

FY2019E revs of £13.5m and EBITDA of £1.6m

 

Aeorema Comms (LON:AEO) 27p £2.35m

 

FYJun18 results from the live events agency.

 

Revenues of £4.8m, a year-on-year increase of 16% (2017: £4.16m)

 

Profit before exceptional items of £0.29m, a year-on-year increase of 17% (2017: £0.25m)

 

Maintained strong cash position with £1.43m in the bank

 

Proposed final dividend payment of 0.75p (2017: 0.5p)

 

“Looking forward to the financial year ended 30 June 2019 and beyond the outlook is very positive. The strength of the new team has led to an excellent series of new business gains since the year end with both existing and new clients. These gains include a major new client in the technology sector and a new global brand within the media sector. The Group continues to win new film production projects and the appointment of Julian Staveley as Experiential Director is also proving successful, with the Group recently winning a roadshow event for a global electronics company.”

 

Immedia (LON:IME) 28.5p £3.42m

 

"Major Service Contract Extension"

 

“The Board announced that Immedia has formally signed a three-year contract with a major UK high street financial institution.

 

The contract, which was the subject of releases by Immedia to the market in March 2017, April 2018 and July 2018, relates to the delivery of live audio stream to all of the institution's consumer retail estate in the UK.

 

Although at this stage the Company is restricted from disclosing any further information, the Board is delighted with the progress of this partnership and will keep shareholders updated as the project progresses.”


Tyman (LON:TYMN) 284p £538.66m

 

The  international supplier of engineered components to the door and window industry, issued a trading update for the period from 30 June 2018 to date. “Revenue and Underlying Operating Profit for the full year for Tyman are expected to be ahead of 2017, with Underlying Operating Profit in line with current market expectations. Free cash flow in the year to date is significantly ahead of 2017.

 

The Group's 2018 performance to date has been assisted by strong contributions from the acquisitions of Ashland and Zoo Hardware. Factors offsetting reported performance include slightly less favourable US Dollar translation exchange rates compared with 2017 and relatively significant input cost inflation across most markets.

 

The market outlook in North America and Continental Europe remains generally positive and the Group expects to make further progress in 2019.

 

As at 6 Nov 2018 the range of analyst estimates compiled by the Group from published research notes for Underlying Operating Profit for the 2018 financial year is between £81.9m and £87.3m (2017 Actual: £76.8m).”

 

Ilika (LON:IKA) 18p £18.13m

 

“The advanced solid-state battery technology and materials innovation company, announces it has achieved the highest energy density to date for its Stereaxâ thin film solid state cells.

 

Since Dec 2016, Ilika has been collaborating with Lightricity Ltd, the ex-Sharp Laboratories of Europe, for the development of an ultra-thin, perpetual IoT power pack combining Lightricity's photovoltaic cells and Ilika's solid state battery technology. During this project, Ilika has optimised the architecture, materials and patterning techniques to yield a battery with improved energy density. The latest batch of prototypes has yielded an energy density more than 3 times that of Ilika's current Stereaxâ M250, with a similar footprint. The capacity of the batteries approaches 1 mAh when cycled at the C/4 cycling rate relevant for the use case, which is a record for Stereax®.”

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use